A Randomized, Assessor-blinded, Parallel Group, Multi-center, Non-inferiority Study Investigating the Efficacy and Safety of Highly Purified Urofollitropin for Injection Compared to Recombinant Human Follitropin Alfa for Injection for Ovulation Induction Using a Low-dose, Step-up Protocol in Chinese Females With WHO Group II Anovulatory Infertility Failing to Conceive on Clomiphene Citrate
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Urofollitropin (Primary) ; Follitropin alfa
- Indications Infertility
- Focus Registrational; Therapeutic Use
- Acronyms Compass
- Sponsors Ferring Pharmaceuticals
- 20 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 13 Apr 2015 Planned number of patients changed from 220 to 212 as reported by ClinicalTrials.gov
- 12 Apr 2015 Planned number of patients changed from 180 to 220 as reported by ClinicalTrials.gov